🧠 Medical Surgical Nursing – NORCET 2025
Parkinson's
Disease
Complete MSN notes covering definition, pathophysiology, TRAP symptoms, Hoehn-Yahr staging, drug therapy (Levodopa-Carbidopa), nursing management, complications and high-yield MCQs for NORCET, AIIMS & State Nursing Exams.
🧠 TRAP Symptoms
💊 Levodopa-Carbidopa
📊 Hoehn-Yahr Scale
🧠 5 Mnemonics
❓ 14 MCQs Included
💡 Definition & Overview
Parkinson's Disease (PD) is a chronic, progressive neurodegenerative disorder characterised by the degeneration of dopaminergic neurons in the substantia nigra of the basal ganglia, leading to dopamine deficiency. It results in a classic triad of tremor, rigidity, and bradykinesia (akinesia). It is the second most common neurodegenerative disease after Alzheimer's disease.
Prevalence
1–2 per 1000
General population
Common Age
> 60 years
Risk doubles each decade
Sex Ratio
Male > Female
1.5 : 1 ratio
Dopamine Loss
> 80%
Before symptoms appear
Rank
2nd Most Common
Neurodegenerative disease
🔬 Pathophysiology
In Parkinson's disease, there is progressive loss of dopamine-producing neurons in the substantia nigra pars compacta (part of basal ganglia). Dopamine normally inhibits excitatory signals and allows smooth, controlled movement. When dopamine ↓, the inhibitory-excitatory balance is disrupted → excessive excitation of motor pathways → rigidity, tremor, slow movement.
Normal State
Dopamine ↑ in Substantia Nigra
→
Balance Maintained
Dopamine inhibits Acetylcholine
→
Smooth Movement
Normal motor function
↓ IN PARKINSON'S ↓
Neuron Death
Substantia Nigra degeneration
→
Dopamine ↓↓
Acetylcholine dominates
→
TRAP Symptoms
Tremor, Rigidity, Akinesia, Postural instability
🧠
Key Pathology Points – Remember This!
Location = Substantia Nigra (Basal Ganglia)
Deficiency = Dopamine ↓↓
Dominance = Acetylcholine ↑ (ACh excess)
Marker = Lewy Bodies (alpha-synuclein)
Type = Extrapyramidal disorder
👉 Lewy Bodies = eosinophilic intracytoplasmic inclusions made of alpha-synuclein — the pathological hallmark of PD found in the substantia nigra neurons.
| Feature | Normal Brain | Parkinson's Brain |
|---|---|---|
| Substantia Nigra | Black pigmented (melanin-rich) neurons present | Depigmented (pale) — neurons destroyed |
| Dopamine | Normal levels | Reduced >80% before symptoms appear |
| Acetylcholine | Balanced with dopamine | Relatively excessive — causes tremor & rigidity |
| Motor control | Smooth, coordinated | Tremor, rigid, bradykinetic |
| Lewy Bodies | Absent | Present — alpha-synuclein deposits |
⚠️ Causes & Risk Factors
| Category | Cause / Risk Factor | Notes |
|---|---|---|
| Idiopathic | Unknown cause | Most Common – 85% of all PD cases |
| Genetic | Mutations in LRRK2, PINK1, SNCA genes | Family history increases risk 2–3× |
| Environmental | Pesticide & herbicide exposure (MPTP, paraquat, rotenone) | Agricultural workers at higher risk |
| Age | Age >60 years | Risk doubles every decade after 60 |
| Sex | Male gender | 1.5× more common in males; oestrogen may be protective |
| Drug-induced | Antipsychotics (haloperidol), metoclopramide, reserpine | Block dopamine receptors → Parkinsonism (reversible) |
| Toxic | Carbon monoxide, manganese, MPTP poisoning | MPTP used in illicit drugs destroys substantia nigra |
| Head Trauma | Repeated head injury (Boxer's Parkinsonism) | Muhammad Ali is a famous example |
| Protective Factors | Smoking, caffeine (coffee), physical exercise | Paradoxically lower PD incidence — mechanism unclear |
🔴 Cardinal Features – The TRAP Symptoms
🚨
MOST High-Yield Exam Topic! The 4 cardinal features of Parkinson's Disease are remembered by the mnemonic TRAP. These appear in nearly every NORCET and nursing exam question on PD.
T
TREMOR
Involuntary rhythmic shaking, most prominent at rest. Disappears during purposeful movement and during sleep.
🖐️ "Pill-rolling tremor" — thumb & index finger roll as if rolling a pill. 4–6 Hz frequency. Classic sign!
R
RIGIDITY
Increased muscle tone / stiffness throughout the full range of passive movement. Both flexors and extensors affected.
⚙️ "Cogwheel rigidity" — jerky, ratchet-like resistance. "Lead-pipe rigidity" — uniform resistance.
A
AKINESIA / BRADYKINESIA
Slowness or absence of voluntary movement. Difficulty initiating movement. Decreased arm swing when walking.
🐌 Bradykinesia = slow movement | Akinesia = no movement | Hypokinesia = reduced movement amplitude
P
POSTURAL INSTABILITY
Impaired balance and righting reflexes → tendency to fall. Stooped forward posture (simian posture).
🚶 Festinating gait — short, shuffling steps, increasing speed involuntarily ("chasing their own centre of gravity")
🧠
Mnemonic – TRAP (Cardinal Features)
Tremor (resting, pill-rolling, 4–6 Hz)
Rigidity (cogwheel / lead-pipe)
Akinesia / Bradykinesia
Postural Instability (festinating gait)
👉 "You are caught in a TRAP if you have Parkinson's" — easiest way to remember all 4 cardinal features!
🩺 Other Clinical Features
| System | Feature | Description |
|---|---|---|
| Motor | Mask-like Face (Hypomimia) | Reduced facial expression — blank, expressionless stare |
| Micrographia | Handwriting becomes progressively smaller | |
| Hypophonia | Soft, monotone, low-pitched voice | |
| Festinating Gait | Short, shuffling, accelerating steps — difficulty stopping | |
| Freezing Episodes | Sudden brief inability to move — "frozen to the spot" | |
| Autonomic | Sialorrhea | Excessive drooling due to swallowing difficulty |
| Seborrhea | Oily, greasy skin (increased sebum production) | |
| Orthostatic Hypotension | Dizziness on standing — fall risk | |
| Cognitive / Psychiatric | Dementia | Late-stage cognitive decline in ~30% of patients |
| Depression / Anxiety | Most common psychiatric complication — affects 50% | |
| Hallucinations | Usually visual — often drug-induced (Levodopa) | |
| Non-motor (Early) | Hyposmia | Loss of smell — often FIRST symptom before motor features |
| REM Sleep Behaviour Disorder | Acting out dreams during sleep — early predictor of PD | |
| Constipation | Reduced GI motility — common non-motor symptom |
🧠
Mnemonic – Non-Motor Early Symptoms of PD
"CRSH before the TRAP!"
Constipation
REM sleep disorder
Smell loss (hyposmia)
Hyposmia / Depression
Non-motor symptoms precede motor symptoms by 10–20 years — they are prodromal signs of PD!
🔍 Diagnosis
Parkinson's Disease is primarily a CLINICAL diagnosis — based on history and neurological examination. There is no single definitive lab test. UK Brain Bank criteria are the gold standard for clinical diagnosis.
| Investigation | Finding | Purpose |
|---|---|---|
| Clinical Diagnosis | TRAP symptoms present, good response to Levodopa | Primary diagnosis — UK Brain Bank Criteria |
| MRI Brain | Usually NORMAL in PD (rules out other causes) | Exclude secondary causes (stroke, tumor, NPH) |
| DaTscan (SPECT) | ↓ Dopamine transporter uptake in striatum | Confirms dopaminergic deficit — most specific test |
| PET Scan | Reduced fluorodopa uptake in basal ganglia | Shows reduced dopamine synthesis |
| Drug Response Test | Significant improvement with Levodopa | Confirms PD diagnosis (vs Parkinson-plus syndromes) |
| Neuropsychological Tests | MMSE, UPDRS (Unified PD Rating Scale) | Assess cognitive and motor function severity |
| Autonomic Tests | Tilt table test for orthostatic hypotension | Assess autonomic dysfunction |
💚
UK Brain Bank Diagnostic Criteria: (1) Bradykinesia PLUS at least one of: Rigidity, 4–6 Hz resting tremor, Postural instability. (2) Positive response to Levodopa. (3) No atypical features suggesting other diagnosis.
📊 Hoehn-Yahr Staging Scale
The Hoehn-Yahr Scale (1967) is the most commonly used staging system for Parkinson's Disease severity. It has 5 stages — from minimal symptoms to complete dependence.
🚨
High-Yield! Hoehn-Yahr Stage 3 = "get-up-and-go" test abnormal, but still INDEPENDENT. Stage 4 = SEVERE disability, still can walk. Stage 5 = Wheelchair/bedridden, fully dependent. These distinctions are tested frequently!
1
Stage 1 – Mild (Unilateral)
- Symptoms on ONE side of body only
- Mild tremor or rigidity, unilateral
- No balance impairment
- Minimal functional impact on daily life
2
Stage 2 – Mild Bilateral
- Bilateral symptoms — both sides of body
- Minimal balance impairment
- Still fully independent
- Postural changes begin (stooped posture)
3
Stage 3 – Moderate
- Mild to moderate bilateral disease
- Postural instability present
- Pull test abnormal
- Still physically independent
- Falls begin to occur
4
Stage 4 – Severe
- Severely disabling symptoms
- Still able to walk and stand
- Requires assistance for some activities
- Cannot live alone safely
5
Stage 5 – End Stage
- Wheelchair-bound or bedridden
- Requires constant nursing care
- Completely dependent for all ADLs
- Severe dementia may be present
🧠
Mnemonic – Hoehn-Yahr Stages (1 to 5)
1 = Unilateral (one side)
2 = Bilateral (both sides, still independent)
3 = Balance impaired (still independent)
4 = Severe (still walks, needs help)
5 = Wheelchair/Bedridden (fully dependent)
👉 "1 Uni → 2 Bi → 3 Balance fails → 4 Severe → 5 Stuck"
💊 Drug Therapy – Pharmacological Management
The goal of drug therapy is to restore the dopamine-acetylcholine balance in the brain. Drugs either increase dopamine, mimic dopamine, prevent its breakdown, or block acetylcholine (to reduce its relative dominance).
Levodopa (L-DOPA)
Gold Standard Drug for PD| Mechanism | Crosses blood-brain barrier → converted to dopamine in brain |
| Given With | Always combined with Carbidopa (inhibits peripheral conversion) |
| Trade Name | Syndopa, Sinemet (Levodopa + Carbidopa) |
| Route | Oral |
| Side Effects | Nausea, vomiting, dyskinesia, on-off phenomenon, hallucinations |
⭐ MOST EFFECTIVE drug for PD. Most common side effects = nausea & dyskinesia. After 5–10 years → "wearing off" effect begins.
Carbidopa
Always combined with Levodopa| Mechanism | Blocks conversion of Levodopa to dopamine in peripheral tissues (does NOT cross BBB) |
| Purpose | Increases amount of Levodopa reaching brain; reduces peripheral side effects (nausea) |
| Cannot | Does NOT work alone — always used WITH Levodopa |
| Ratio | Carbidopa : Levodopa = 1:4 or 1:10 |
| Benefit | Reduces Levodopa dose needed by 75% |
🔑 Carbidopa alone has NO anti-Parkinson effect. It ONLY works to improve Levodopa efficacy by reducing peripheral breakdown.
Dopamine Agonists
Pramipexole, Ropinirole, Bromocriptine| Mechanism | Directly stimulate dopamine receptors in brain — mimic dopamine action |
| Use | Early PD (young onset), adjunct to Levodopa, or Levodopa-intolerant patients |
| Examples | Pramipexole, Ropinirole (oral); Rotigotine (patch); Apomorphine (injection) |
| Side Effects | Nausea, somnolence, hallucinations, impulse control disorders (gambling, hypersexuality) |
⚠️ Impulse control disorders (compulsive gambling, binge eating, hypersexuality) are characteristic side effects of dopamine agonists — a commonly asked MCQ!
MAO-B Inhibitors
Selegiline, Rasagiline| Mechanism | Inhibit MAO-B enzyme which normally breaks down dopamine → dopamine levels ↑ in brain |
| Use | Early PD monotherapy; adjunct to Levodopa in later stages |
| Examples | Selegiline (Deprenyl), Rasagiline |
| Neuroprotective? | May have neuroprotective effect (slows disease progression) |
| Interaction | Avoid with meperidine (pethidine) — fatal serotonin syndrome risk! |
⚠️ Selegiline + Meperidine = DANGEROUS COMBINATION (serotonin syndrome). This is a very high-yield drug interaction tested in nursing exams!
COMT Inhibitors
Entacapone, Tolcapone| Mechanism | Inhibit COMT enzyme that breaks down Levodopa peripherally → more Levodopa reaches brain |
| Use | Adjunct to Levodopa/Carbidopa to reduce "wearing-off" effect |
| Examples | Entacapone (preferred), Tolcapone (liver toxicity risk) |
| Side Effects | Diarrhoea, urine discolouration (orange), dyskinesia, liver toxicity (tolcapone) |
⚠️ Entacapone turns urine orange — warn patients! Tolcapone requires liver function monitoring due to hepatotoxicity risk.
Anticholinergics
Trihexyphenidyl (Artane), Benztropine| Mechanism | Block excess acetylcholine (ACh) activity → restore DA:ACh balance |
| Best For | Predominantly TREMOR (less effective for bradykinesia & rigidity) |
| Examples | Trihexyphenidyl (Artane), Benztropine (Cogentin), Biperiden |
| Avoid In | Elderly — worsens confusion, memory; prostatic hypertrophy; glaucoma |
| Side Effects | Dry mouth, urinary retention, constipation, blurred vision, confusion |
⚠️ Anticholinergics are AVOIDED in elderly patients (>70 yrs) as they worsen dementia and cognition. Use with caution!
Amantadine
Anti-viral with Anti-Parkinson effect| Mechanism | Increases dopamine release + blocks NMDA (glutamate) receptors |
| Use | Early PD monotherapy; very effective for drug-induced dyskinesia |
| Origin | Initially anti-influenza drug — anti-PD effect discovered accidentally |
| Side Effects | Livedo reticularis (mottled skin), ankle edema, confusion, hallucinations |
💡 Amantadine causes Livedo Reticularis (bluish-purple mottled skin pattern) — a characteristic side effect tested in exams!
🧠
Mnemonic – Drug Classes for PD
"Lovely Doctors Make Careful Attempts Always"
Levodopa (Gold standard)
Dopamine Agonists (Pramipexole)
MAO-B Inhibitors (Selegiline)
COMT Inhibitors (Entacapone)
Anticholinergics (Trihexyphenidyl)
Amantadine
⚠️ Levodopa Complications – High Yield!
| Complication | Description | Management |
|---|---|---|
| On-Off Phenomenon | Sudden unpredictable fluctuation between normal motor function ("on") and severe Parkinsonism ("off") — occurs after years of therapy | Adjust dosing schedule; add COMT inhibitor or DA agonist |
| Wearing-Off Effect | Drug effect diminishes before next dose — symptoms return at end of each dose (predictable) | Increase dose frequency; add adjuncts |
| Dyskinesia | Involuntary abnormal movements (choreiform, writhing) — occur at peak drug level | Reduce Levodopa dose; add Amantadine |
| Drug Holiday | Planned withdrawal from Levodopa for 1 week to restore drug sensitivity | Done in hospital — risk of NMS (Neuroleptic Malignant Syndrome) |
| Neuroleptic Malignant Syndrome (NMS) | High fever, muscle rigidity, autonomic instability, altered consciousness — life threatening | Stop offending drug; Bromocriptine + Dantrolene |
🏥 Surgical Management
| Procedure | Mechanism | Best For |
|---|---|---|
| Deep Brain Stimulation (DBS) | Electrodes implanted in subthalamic nucleus or globus pallidus; high-frequency electrical stimulation suppresses abnormal signals | Gold Standard Surgery — drug-refractory cases; reduces tremor, rigidity, dyskinesia |
| Thalamotomy | Surgical destruction of part of thalamus (ventral intermediate nucleus) | Severe unilateral tremor; done less often now (DBS preferred) |
| Pallidotomy | Surgical destruction of globus pallidus interna | Reduces dyskinesia and rigidity; rarely done now |
| Stem Cell Therapy | Experimental — transplantation of dopaminergic neurons | Still under research; not standard practice |
💚
DBS (Deep Brain Stimulation) is the most important surgical treatment — it is reversible and adjustable (unlike thalamotomy/pallidotomy which are destructive). The device is like a brain pacemaker! Very commonly asked in NORCET.
👩⚕️ Nursing Management
Mobility & Safety
- Assess gait, balance, fall risk (use fall scale)
- Encourage walking with wide-based gait
- Use assistive devices — walking frame, cane
- Remove rugs, obstacles from environment
- Non-slip footwear at all times
- Bed rails up; call bell within reach
- Teach "count 1-2-3 before stepping" to prevent freezing
Nutrition & Swallowing
- Assess swallowing — dysphagia common
- Refer to speech therapist if needed
- Soft, easy-to-chew diet
- High-fibre diet — prevents constipation
- Adequate fluid intake (2–2.5 L/day)
- Give Levodopa 30 min BEFORE meals (food delays absorption)
- Avoid high-protein meals near Levodopa dose — protein competes with Levodopa absorption
Medication Management
- Give medications on STRICT schedule — never delay
- Monitor for "on-off" phenomenon and wearing-off
- Observe for dyskinesia at peak dose
- Never stop Levodopa abruptly — risk of NMS
- Monitor for hallucinations (Levodopa side effect)
- Teach patient/family about drug schedule
Communication
- Hypophonia — speak slowly, clearly
- Face patient when speaking
- Use communication boards if needed
- LSVT LOUD therapy (Lee Silverman Voice Treatment)
- Encourage reading aloud to maintain voice volume
- Allow extra time for patient to respond
Psychological Support
- Assess for depression (most common psychiatric feature)
- Encourage independence — avoid over-helping
- Support groups for patient and caregivers
- Refer to psychiatrist if depression/anxiety severe
- Maintain social interactions to prevent isolation
Exercise & Rehabilitation
- Physical therapy — range of motion exercises daily
- Gait training — visual cues (lines on floor)
- Occupational therapy for ADL independence
- Balance exercises to reduce fall risk
- Encourage Tai Chi, yoga (proven to help PD)
- LSVT BIG therapy — large amplitude movements
⚠️ Complications of Parkinson's Disease
| Complication | Description | Prevention / Management |
|---|---|---|
| Falls & Fractures | Most common complication — postural instability + festinating gait | Most Common — fall prevention protocol, safe environment |
| Aspiration Pneumonia | Dysphagia → food/fluids aspirated → pneumonia | Leading cause of death — speech therapy, modified diet |
| Pressure Ulcers | Immobility in late stages → pressure injury | Regular repositioning, pressure-relieving mattress |
| Deep Vein Thrombosis | Immobility → venous stasis → DVT | Leg exercises, compression stockings, early mobilisation |
| Dementia | 30% develop dementia in late stages (Lewy Body Dementia) | Cognitive stimulation; avoid anticholinergics |
| Depression | 50% of PD patients develop depression (dopamine deficiency in limbic system) | SSRIs; psychological support |
| NMS | Abrupt discontinuation of Levodopa → life-threatening hyperthermia, rigidity | Never stop Levodopa suddenly; treat with bromocriptine + dantrolene |
🚨
Most Important! Aspiration Pneumonia is the leading cause of death in Parkinson's Disease patients. Falls are the most common complication. Depression is the most common psychiatric complication (50%). All three are high-yield for NORCET!
📋 Parkinson's vs Alzheimer's Disease – Key Differences
| Feature | Parkinson's Disease | Alzheimer's Disease |
|---|---|---|
| Primary Deficiency | Dopamine ↓ (substantia nigra) | Acetylcholine ↓ (hippocampus, cortex) |
| Pathological Marker | Lewy Bodies (alpha-synuclein) | Amyloid plaques + Neurofibrillary tangles (tau) |
| Main Symptom | Motor: tremor, rigidity, bradykinesia | Memory loss (cognitive symptoms first) |
| Tremor | Resting tremor (pill-rolling) | Not a primary feature |
| Drug Therapy | Levodopa + Carbidopa (increases dopamine) | Donepezil, Memantine (increases ACh) |
| Onset | Usually after age 60 | Usually after age 65 |
| Most Common Neurodegen. | 2nd most common | 1st most common |
📝 High-Yield MCQs – Parkinson's Disease (NORCET 2025)
Q1. The pathological hallmark of Parkinson's Disease found on brain biopsy is?
- A) Amyloid plaques
- B) Neurofibrillary tangles
- C) Lewy Bodies (alpha-synuclein inclusions)
- D) Pick bodies
💡 Tip: Lewy Bodies = eosinophilic intracytoplasmic inclusions of alpha-synuclein in substantia nigra neurons. Amyloid plaques + tangles = Alzheimer's. Pick bodies = Pick's disease. Very high-yield distinction!
Q2. The TRAP mnemonic for Parkinson's Disease stands for?
- A) Tremor, Resistance, Ataxia, Pain
- B) Tremor, Rigidity, Akinesia, Postural instability
- C) Tremor, Rigidity, Ataxia, Paralysis
- D) Tachycardia, Rigidity, Akinesia, Psychosis
💡 Tip: TRAP = Tremor (resting, pill-rolling) + Rigidity (cogwheel) + Akinesia/Bradykinesia + Postural instability. These 4 cardinal features are the foundation of every PD question in NORCET!
Q3. The classic tremor of Parkinson's Disease is described as?
- A) Intention tremor during voluntary movement
- B) Resting "pill-rolling" tremor at 4–6 Hz
- C) Postural tremor on holding a position
- D) Action tremor worsened by caffeine
💡 Tip: Resting tremor (present at rest, disappears with purposeful movement) = Parkinson's. Intention tremor (occurs during movement) = Cerebellar disease. Pill-rolling (thumb + index finger) at 4–6 Hz is pathognomonic of PD.
Q4. Why is Carbidopa ALWAYS combined with Levodopa in Parkinson's treatment?
- A) Carbidopa enhances dopamine effect in the brain
- B) Carbidopa crosses the blood-brain barrier to act on neurons
- C) Carbidopa prevents peripheral conversion of Levodopa, allowing more to reach the brain
- D) Carbidopa blocks acetylcholine receptors
💡 Tip: Carbidopa inhibits DOPA decarboxylase peripherally (does NOT cross BBB) → prevents Levodopa from being converted to dopamine outside the brain → more Levodopa reaches brain → better efficacy + fewer peripheral side effects (nausea, vomiting).
Q5. The GOLD STANDARD surgical treatment for refractory Parkinson's Disease is?
- A) Thalamotomy
- B) Pallidotomy
- C) Deep Brain Stimulation (DBS)
- D) Stereotactic radiosurgery
💡 Tip: DBS = electrodes in subthalamic nucleus or globus pallidus + pulse generator under skin. It is REVERSIBLE and adjustable — like a brain pacemaker. Preferred over thalamotomy/pallidotomy which are destructive and irreversible.
Q6. A patient with Parkinson's Disease develops sudden unpredictable switching between being mobile and severely immobile. This is called?
- A) Wearing-off effect
- B) On-Off phenomenon
- C) Drug tolerance
- D) Dyskinesia
💡 Tip: On-Off = sudden UNPREDICTABLE fluctuations (like a switch). Wearing-off = PREDICTABLE end-of-dose deterioration before next dose. Dyskinesia = involuntary movements at PEAK drug level. These 3 Levodopa complications are all high-yield!
Q7. In Hoehn-Yahr Stage 5, the patient with Parkinson's Disease would be?
- A) Unilateral symptoms only, independent
- B) Bilateral symptoms, still independent
- C) Severe disability, still able to walk
- D) Wheelchair-bound or bedridden, fully dependent
💡 Tip: Stage 1 = Unilateral. Stage 2 = Bilateral. Stage 3 = Postural instability but independent. Stage 4 = Severe, still walks. Stage 5 = Wheelchair/bedridden, fully dependent. Key distinction: Stage 3 vs 4 = both have bilateral disease but Stage 3 is still independent!
Q8. The type of rigidity described in Parkinson's Disease with a ratchet-like feel on passive movement is?
- A) Clasp-knife rigidity
- B) Spastic rigidity
- C) Cogwheel rigidity
- D) Flaccid rigidity
💡 Tip: Cogwheel rigidity = jerky, ratchet-like resistance (tremor superimposed on lead-pipe rigidity) = Parkinson's. Lead-pipe rigidity = uniform resistance throughout ROM = also PD. Clasp-knife = Upper Motor Neuron lesion (stroke, spinal cord injury).
Q9. The MOST COMMON cause of death in Parkinson's Disease patients is?
- A) Stroke
- B) Cardiac failure
- C) Aspiration pneumonia
- D) Renal failure
💡 Tip: Dysphagia → aspiration of food/secretions into lungs → aspiration pneumonia → leading cause of death in PD. Falls are the most common complication. Depression is most common psychiatric feature. But DEATH is due to aspiration pneumonia!
Q10. Which drug used in Parkinson's Disease causes "Livedo Reticularis" as a side effect?
- A) Levodopa
- B) Selegiline
- C) Amantadine
- D) Pramipexole
💡 Tip: Amantadine causes livedo reticularis — a bluish-purple mottled network pattern on skin (especially legs). This is its characteristic and unique side effect. Also causes ankle oedema. Commonly tested!
Q11. A nurse is teaching a patient taking Levodopa-Carbidopa. Which dietary instruction is MOST important?
- A) Eat a high-protein diet with every dose
- B) Take medication with dairy products
- C) Avoid taking medication with high-protein meals as protein competes with Levodopa absorption
- D) Take medication after a full meal to prevent nausea
💡 Tip: Large neutral amino acids (from protein) compete with Levodopa for absorption in the intestine and transport across the BBB. Take Levodopa 30–60 minutes BEFORE meals or with low-protein snacks. This is a very common patient education question!
Q12. The dangerous drug interaction that occurs between Selegiline (MAO-B inhibitor) and which drug can cause serotonin syndrome?
- A) Aspirin
- B) Metformin
- C) Meperidine (Pethidine)
- D) Amoxicillin
💡 Tip: Selegiline + Meperidine = potentially FATAL combination causing serotonin syndrome (hyperthermia, rigidity, seizures, death). Also avoid Selegiline with other MAO inhibitors, SSRIs, and TCAs. This is a high-yield drug interaction for NORCET!
Q13. The earliest non-motor symptom of Parkinson's Disease that often precedes motor features by years is?
- A) Dementia
- B) Depression
- C) Hyposmia (loss of smell)
- D) Constipation
💡 Tip: Hyposmia (reduced sense of smell) is the EARLIEST prodromal symptom — can occur 10–20 years before motor symptoms. REM sleep behaviour disorder and constipation are also early signs. This is increasingly tested in updated NORCET questions!
Q14. When teaching a patient with Parkinson's Disease about fall prevention, the nurse should instruct to?
- A) Take quick, small steps to maintain balance
- B) Wear loose, comfortable slippers
- C) Walk with a wide base of support and use visual cues like floor lines
- D) Avoid walking aids as they create dependence
💡 Tip: Wide base of support improves stability. Visual cues (floor lines, marks) help overcome "freezing." Non-slip, closed footwear (NOT slippers) reduces fall risk. Assistive devices (walker, cane) IMPROVE independence — never discourage them!
⚡ Quick Reference – Parkinson's Disease
Cardinal Features
TRAP (Tremor, Rigidity, Akinesia, Postural)
Classic Tremor
Pill-rolling, 4–6 Hz, resting
Rigidity Type
Cogwheel / Lead-pipe
Pathology
Lewy Bodies in Substantia Nigra
Neurotransmitter ↓
Dopamine ↓ (>80% before symptoms)
Gold Standard Drug
Levodopa + Carbidopa
Best Surgery
Deep Brain Stimulation
COPD of PD Drug
Ventrogluteal
Leading Cause of Death
Aspiration Pneumonia
Most Common Complication
Falls
Amantadine Side Effect
Livedo Reticularis
Hoehn-Yahr Stage 5
Wheelchair/Bedridden
Selegiline + ?
Meperidine = serotonin syndrome
Early Non-motor Sign
Hyposmia (loss of smell)
Drug Mnemonics
Lovely Doctors Make Careful Attempts Always
2nd Common Neurodegen.
Parkinson's (after Alzheimer's)
Comments
Post a Comment